Researcher | Stanford University School of Medicine | United States
Dr. Farbod Tabesh is a multidisciplinary chemist whose research bridges organic chemistry, polymer science, nanotechnology, and biomedical engineering to advance next-generation therapeutic and diagnostic platforms. His scientific contributions span the design, synthesis, and functionalization of hydrogels, natural and synthetic polymers, lipid-, metal-organic-, magnetic-, and polymeric nanoparticles, as well as multifunctional nanocomposites engineered for cancer therapy, molecular imaging, and gene delivery. With expertise in peptide synthesis, polymer–biomolecule conjugation, immune checkpoint imaging, suicide gene therapy, and targeted microbubble-based ultrasound diagnostics, his work addresses urgent challenges in oncology, regenerative medicine, and precision health. At Stanford University School of Medicine, Dr. Tabesh has led and contributed to projects involving polymeric nanocarriers for gene therapy, contrast-enhanced ultrasound imaging of tumor-specific biomarkers, microbubble-assisted miRNA delivery for veterinary oncology, and RNA-based vaccine development. His portfolio includes impactful publications in materials science, imaging, and nanomedicine, along with manuscripts in preparation on PD-L1 vascular imaging, targeted nanocomposite delivery systems, and chitosan-poly(ethylene imine) copolymer therapeutics for breast cancer. Dr. Tabesh’s research trajectory also reflects strong collaboration with leading experts in molecular imaging, cancer biology, and translational nanomedicine, contributing to clinically oriented platforms with clear societal benefit. His scientific influence is further demonstrated by 473 citations across 418 documents, 21 publications, and an h-index of 9, underscoring his growing global impact in polymer-based therapeutics and molecular imaging. He has earned multiple distinctions, including awards for poster and presentation excellence and recognition through the WMIC Student Travel Award. Dr. Tabesh’s work continues to advance the integration of smart biomaterials with molecular imaging and targeted therapy, contributing to more precise, biocompatible, and personalized healthcare solutions.
Profiles: Google Scholar | Scopus | ORCID | ResearchGate
Featured Publications
-
Mallakpour, S., Tabesh, F., & Hussain, C. M. (2021). 3D and 4D printing: From innovation to evolution. Advances in Colloid and Interface Science, 294, 102482. Citations: 117
-
Mallakpour, S., & Tabesh, F. (2019). Tragacanth gum based hydrogel nanocomposites for the adsorption of methylene blue: Comparison of linear and non-linear forms of different adsorption isotherm and kinetics models. International Journal of Biological Macromolecules, 133, 754–766. Citations: 108
-
Mallakpour, S., Tabesh, F., & Hussain, C. M. (2022). A new trend of using poly(vinyl alcohol) in 3D and 4D printing technologies: Process and applications. Advances in Colloid and Interface Science, 301, 102605. Citations: 82
-
Mallakpour, S., Abdolmaleki, A., & Tabesh, F. (2018). Ultrasonic-assisted manufacturing of new hydrogel nanocomposite biosorbent containing calcium carbonate nanoparticles and tragacanth gum for removal of heavy metal. Ultrasonics Sonochemistry, 41, 572–581. Citations: 79
-
Mallakpour, S., & Tabesh, F. (2021). Green and plant-based adsorbent from tragacanth gum and carboxyl-functionalized carbon nanotube hydrogel bionanocomposite for the super removal of methylene blue dye. International Journal of Biological Macromolecules, 166, 722–729. Citations: 60